Ligand validation:8ASZ

AG2: AGMATINE

AG2 is a Ligand Of Interest in 8ASZ designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8ASZ_AG2_A_401	97%	5%	0.058	0.972	2.34	3.01	3	2	0	0	100%	1
6YE6_AG2_B_402	32%	10%	0.161	0.832	3.4	0.93	2	1	1	0	100%	1
9JF5_AG2_G_601	96%	75%	0.056	0.966	0.58	0.41	-	-	1	0	100%	1
9JFN_AG2_E_601	90%	73%	0.072	0.953	0.56	0.48	-	-	0	0	100%	1
1N13_AG2_B_7011	89%	93%	0.075	0.953	0.29	0.2	-	-	0	0	100%	1
6S49_AG2_A_501	83%	78%	0.099	0.959	0.55	0.35	-	-	0	0	100%	1
2QQC_AG2_K_671	76%	86%	0.127	0.965	0.46	0.26	-	-	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.